Allison M Dostal1, Andrea Arikawa2, Luis Espejo1, Mindy S Kurzer3. 1. Department of Food Science and Nutrition, University of Minnesota, St. Paul, MN; and. 2. Department of Nutrition and Dietetics, University of North Florida, Jacksonville, FL. 3. Department of Food Science and Nutrition, University of Minnesota, St. Paul, MN; and mkurzer@umn.edu.
Abstract
BACKGROUND:Green tea extract (GTE) consumption has been linked to favorable changes in adiposity and bone mineral density (BMD), although it is unknown if these effects are due to green tea catechins or caffeine. The catechol-O-methyltransferase (COMT) genotype may also modify these associations. OBJECTIVE: We examined the impact of decaffeinated GTE on body composition (using dual-energy X-ray absorptiometry) and obesity-associated hormones. METHODS: The Minnesota Green Tea Trial was a 12-mo randomized, double-blind, placebo-controlled clinical trial in 937 postmenopausal women (aged 50-70 y) assigned to receive either GTE containing 843 mg (-)-epigallocatechin-3-gallate or placebo. This substudy was conducted in 121 overweight/obese participants [body mass index (BMI) (kg/m(2)) ≥25.0]. RESULTS: There were no differences in changes in BMI (-0.13 ± 0.11 compared with -0.05 ± 0.11; P = 0.61), total fat mass (-0.30 ± 0.16 compared with -0.12 ± 0.15 kg; P = 0.40), percentage of body fat (-0.15% ± 0.17% compared with -0.15% ± 0.16%; P = 0.99), or BMD (-0.006 ± 0.002 compared with -0.003 ± 0.002 g/cm(2); P = 0.49) over 12 mo between women taking GTE (n = 61) and those taking a placebo (n = 60). Interactions were observed between treatment and time for gynoid percentage of fat (%fat) and tissue %fat. Gynoid %fat increased from baseline to month 12 in the placebo group as baseline BMI increased and decreased over time as baseline BMI increased in the GTE group (P-interaction = 0.02). Tissue %fat increased from baseline to month 12 in the placebo group as baseline BMI increased. In the GTE group, tissue %fat decreased during the intervention as baseline BMI increased (P-interaction = 0.04). No changes were seen in circulating leptin, ghrelin, adiponectin, or insulin concentrations. COMT genotype did not modify the effect of GTE on any variable. CONCLUSIONS:Decaffeinated GTE was not associated with overall reductions in adiposity or improvements in BMD in overweight/obese postmenopausal women. However, GTE may be beneficial for reduction in tissue and gynoid %fat in individuals with higher BMI. This clinical trial was registered at www.clinicaltrials.gov as NCT00917735.
RCT Entities:
BACKGROUND: Green tea extract (GTE) consumption has been linked to favorable changes in adiposity and bone mineral density (BMD), although it is unknown if these effects are due to green tea catechins or caffeine. The catechol-O-methyltransferase (COMT) genotype may also modify these associations. OBJECTIVE: We examined the impact of decaffeinated GTE on body composition (using dual-energy X-ray absorptiometry) and obesity-associated hormones. METHODS: The Minnesota Green Tea Trial was a 12-mo randomized, double-blind, placebo-controlled clinical trial in 937 postmenopausal women (aged 50-70 y) assigned to receive either GTE containing 843 mg (-)-epigallocatechin-3-gallate or placebo. This substudy was conducted in 121 overweight/obeseparticipants [body mass index (BMI) (kg/m(2)) ≥25.0]. RESULTS: There were no differences in changes in BMI (-0.13 ± 0.11 compared with -0.05 ± 0.11; P = 0.61), total fat mass (-0.30 ± 0.16 compared with -0.12 ± 0.15 kg; P = 0.40), percentage of body fat (-0.15% ± 0.17% compared with -0.15% ± 0.16%; P = 0.99), or BMD (-0.006 ± 0.002 compared with -0.003 ± 0.002 g/cm(2); P = 0.49) over 12 mo between women taking GTE (n = 61) and those taking a placebo (n = 60). Interactions were observed between treatment and time for gynoid percentage of fat (%fat) and tissue %fat. Gynoid %fat increased from baseline to month 12 in the placebo group as baseline BMI increased and decreased over time as baseline BMI increased in the GTE group (P-interaction = 0.02). Tissue %fat increased from baseline to month 12 in the placebo group as baseline BMI increased. In the GTE group, tissue %fat decreased during the intervention as baseline BMI increased (P-interaction = 0.04). No changes were seen in circulating leptin, ghrelin, adiponectin, or insulin concentrations. COMT genotype did not modify the effect of GTE on any variable. CONCLUSIONS:Decaffeinated GTE was not associated with overall reductions in adiposity or improvements in BMD in overweight/obese postmenopausal women. However, GTE may be beneficial for reduction in tissue and gynoid %fat in individuals with higher BMI. This clinical trial was registered at www.clinicaltrials.gov as NCT00917735.
Authors: Chwan-Li Shen; Gordon Brackee; Xiao Song; Michael D Tomison; VelvetLee Finckbone; Kelly T Mitchell; Lili Tang; Ming-Chien Chyu; Dale M Dunn; Jia-Sheng Wang Journal: J Food Sci Date: 2017-07-28 Impact factor: 3.167
Authors: Nagi B Kumar; Roshni Patel; Julio Pow-Sang; Philippe E Spiess; Raoul Salup; Christopher R Williams; Michael J Schell Journal: Oncotarget Date: 2017-06-29
Authors: Xing Wang; Jun Huang; Fan Huang; Jian-Chun Zong; Xi Tang; Yang Liu; Qiong-Fang Zhang; Yang Wang; Liang Chen; Liang-Jun Yin; Bai-Cheng He; Zhong-Liang Deng Journal: Mol Med Rep Date: 2017-03-09 Impact factor: 2.952
Authors: André C Carpentier; Denis P Blondin; Kirsi A Virtanen; Denis Richard; François Haman; Éric E Turcotte Journal: Front Endocrinol (Lausanne) Date: 2018-08-07 Impact factor: 5.555
Authors: John A Batsis; John W Apolzan; Pamela J Bagley; Heather B Blunt; Vidita Divan; Sonia Gill; Angela Golden; Shalini Gundumraj; Steven B Heymsfield; Scott Kahan; Katherine Kopatsis; Ava Port; Elizabeth Prout Parks; Clifford A Reilly; Domenica Rubino; Katherine H Saunders; Ryan Shean; Luai Tabaza; Abishek Stanley; Beverly G Tchang; Shivani Gundumraj; Srividya Kidambi Journal: Obesity (Silver Spring) Date: 2021-07 Impact factor: 9.298